The trademark BCOVAXIN was filed by Bharat Biotech International Limited, a corporation established under the laws of the Republic of India (the "Applicant"). The application was published for oppositions on March 11, 2021, and received one opposition filed on March 16, 2021 by Sanofi Pasteur Europe on Likelihood of confusion. the opponent was represented by CASALONGA ALICANTE, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 16, 2021
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).